Novo Nordisk A/S Class B
Common Stock · DKK · XETRA
Price
DKK 291.05
Cap
DKK 19.90B
Earnings
—
30d Trend
+10.5%
58% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 53×Macro 0.99 (−1%)=52
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate Novo Nordisk A/S Class B at 52/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 75/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+15.5%
3 MONTHS
+26.9%
12 MONTHS
-32.2%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Quality (75) and Fundamentals (75) are the primary strengths. I note that momentum is the weakest area at 17/100 — this warrants monitoring. Historical volatility is elevated at 58%. I classify this as a speculative position — elevated volatility at 58% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.